ICON plc announced the pricing of a $2.15 billion private offering of senior unsecured notes, consisting of $500 million of 5.064% Notes due 2029, $1.0 billion of 5.421% Notes due 2031, and $650 million of 5.995% Notes due 2036. The offering is expected to close on August 13, 2026, subject to customary conditions. Net proceeds will repay the bridge facility credit agreement, outstanding senior secured term loans, and fully redeem the 5.809% Senior Secured Notes due 2027. Repayment of these obligations will release collateral securing the revolving credit facility and existing notes, while releasing subsidiary guarantees under those instruments. ICON plc is a world-leading clinical research organization that provides integrated consulting, clinical development, commercialization, and post-marketing solutions to pharmaceutical, biotechnology, medical device, government, and public health organizations.
